Pharmaceuticals

Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery

 MILAN, July 17, 2025 /PRNewswire/ --?A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing ananti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of...

2025-07-17 17:00 1543

Total Investment of Approx. USD 7.3 Million in Malaria and TB R&D Projects With Partners Including European Vaccine Initiative, University of Copenhagen, and University of Tübingen

 TOKYO, July 17, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund?announced today a total investment of approximatelyJPY 1 billion ( USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 Investment o...

2025-07-17 10:00 1483

ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO

 SHANGHAI, July 16, 2025 /PRNewswire/ -- In the newly released "Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report" by Global Accelerator for Paediatric formulations (GAP-f), the World Health Organization (WHO) host network,ziresovir (10mg) has been included in ...

2025-07-16 09:00 1839

Bio Investments Group (BIG) and International Vaccine Institute (IVI) Forge Partnership to Accelerate Vaccine Self-Reliance in Africa and the Middle East

 ZUG, Switzerland and SEOUL, July 11, 2025 /PRNewswire/ -- The Bio Investments Group AG (BIG), a leading global healthcare-technology transfer platform, and the International Vaccine Institute (IVI), an international organization dedicated to advancing vaccine discovery, development, and delivery,...

2025-07-11 23:08 3447

DKSH and Bayer Launch Strategic Partnership Across Multiple Markets in Southeast Asia

 DKSH has signed ?a strategic business partnership with life science company Bayer, to provide comprehensive services for a portion of the Bayer Pharmaceuticals business in Singapore, Malaysia, Thailand and the Philippines. SINGAPORE, July 10, 2025 /PRNewswire/ --?DKSH Business Unit Healthcare, ...

2025-07-10 10:00 2614

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico's Life Sciences Market

 NORWALK,?Conn., July 9, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution?in North America, is pleased to announce the expansion of its distribution partnership with Clariant, a global leader in the development and manufacturing of specialty c...

2025-07-09 23:00 1861

NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports

 NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.? ? NYSE Content advisory: Pre-Market update + Trump announces 50% le...

2025-07-09 20:55 2955

IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel

 SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ --?IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced thatits self-developed an...

2025-07-09 20:18 1712

Gozellix Receives Permanent HCPCS Code

 MELBOURNE, Australia, July 9, 2025 /PRNewswire/ --?Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix? (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Hea...

2025-07-09 12:41 2892

Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025

 TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the?Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp ...

2025-07-09 11:30 1786

GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS

 #HopeNeedsAHome Cypress Minerals and Cepham Inc lead Fundraising Efforts Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home $140,000 USD needed by August 15 to Secure Home for young Mothers MADERA, Calif., July 8, 2025 /PRNewswire/ -- Tw...

2025-07-08 20:00 1369

SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V

 SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced?today that the China National Medical Products Administration (NMPA) has cleared the Investigation...

2025-07-08 10:02 3105

Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai

 SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted?the "2025 Everest Medicines mRNA Platform R&D Day" in Shanghai. The e...

2025-07-04 16:58 2693

Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai

 SHENZHEN, China, July 4, 2025 /PRNewswire/ -- Recently, Kexing Biopharm made a remarkable appearance at CPHI & PMEC China 2025 and successfully organized the 2025 International Pharmaceutical Cooperation High-End Forum, one of the Kexing Biopharm's series of globalization activities in Shanghai. ...

2025-07-04 16:26 2537

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

 * Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China * Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and?BEIJING, J...

2025-07-04 08:30 2634

Everest Medicines Announces Updated Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy

 * As of March 21st, 2025, longer follow-up data was collected from the ongoing Ph1b/2a study of EVER001: in Cohort 1, 11 patients completed 52 weeks of follow-up. In Cohort 2, 7 patients completed 52 weeks of follow-up. * The updated data showed that EVER001 was well-tolerated and efficacious ...

2025-07-02 15:33 1751

Seegene Launches STAgora?, a New Platform for Infectious Disease Analytics

 * Real-time analytics that empower clinical decision-making and pandemic preparedness * Global unveiling at?ADLM 2025 in Chicago to initiate business partnerships * Powered by AI and?syndromic PCR to enable early detection and predictive insights SEOUL, South Korea, July 1, 2025 /PRNewswire/...

2025-07-01 22:09 2224

FAIR PLAY MENARINI INTERNATIONAL AWARD, LUIS FIGO JOINS THE GREAT SPORTS STARS ACKNOWLEDGED IN 2025

 FLORENCE, Italy, July 1, 2025 /PRNewswire/ -- Surprises never end when it comes to theFair Play Menarini International Award: Luís Figo, European football legend and true icon of sporting integrity, will be among the awardees of the 29th edition of the event, taking place onJuly 2nd and 3rd in Fl...

2025-07-01 21:10 2109

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

 NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO ) today announced that it is moving forward with manufacturing and process development work in preparation for clinical trials of KLTO-202, its investigational gene therapy for amyotrophic lateral sclerosis (ALS). A ...

2025-06-30 14:00 1203

ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment

 LONDON, June 29, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective...

2025-06-29 06:01 2454
12345678 ... 190